Uncategorized

DC Medicaid Becomes the First Medicaid Plan to Cover the Nerivio® REN Wearable, a Non-Drug Treatment for Migraine

Theranica, a neuromodulation therapeutics company, today announced DC Medicaid’s coverage of the Nerivio® REN wearable, the first and only FDA-cleared, non-drug, non-disruptive treatment for both acute attacks and prevention of migraine with or without aura in adolescents and adults ages 12 and older.

DC Medicaid Becomes the First Medicaid Plan to Cover the Nerivio® REN Wearable, a Non-Drug Treatment for Migraine Read More »

Scroll to Top